John Fralick


Articles and Opinion Pieces by this author

Episode 18 – Equity, diversity and inclusion in medicine: Interview w Dr. Ruzycki

Welcome back Rounds Table Listeners! This week we sit down with Dr. Shannon Ruzycki, an Internal Medicine Specialist at the Foothills Medical Centre and Clinical Assistant Professor at the Cumming School of Medicine at the University of Calgary. She joins us to share her research and experience in equity, diversity, and inclusion in medicine. You…

Episode 17 – Interview with Dr. Tremblay: CATCO & COVID19

Welcome back Rounds Table listeners! This week, we are joined by Dr. Alain Tremblay. Dr. Tremblay is a respirologist at the Foothills Medical Centre and a Professor at the Cumming School of Medicine at the University of Calgary. He’s also the local site lead for the CATCO COVID19 treatment trial, which is the Canadian arm of…

Episode 15 – Hematology Rapid Fire!

Welcome back Rounds Table Listeners! Just before COVID was starting to take off we had recorded a non-COVID episode on four hematology papers, but we never got around to releasing the episode. Well, better late than never…Four rapid fire papers on hematology topics that have nothing to do with COVID-19! Is an incidental lymphopenia associated…

Episode 12 – Rapid Fire Treatment Options for COVID-19

Welcome back Rounds Table Listeners! This week we are going back to our Rapid Fire Format to review two papers looking at new data on treatment options for patients with COVID-19. Is Remdesivir effective in the treatment of COVID-19? https://www.nejm.org/doi/full/10.1056/NEJMoa2007764 Is Lopinavir-ritonavir effective in the treatment of COVID-19? https://www.nejm.org/doi/full/10.1056/NEJMoa2001282   And for The Good Stuff….…

Episode 11 – Interview with Dr. Donald Arnold, lead for the CONCOR-1 trial

Welcome back Rounds Table Listeners! This week we interview Dr. Donald Arnold, a McMaster University professor and hematologist who is leading the CONCOR-1 trial. The CONvalescent Plasma for COVID-19 Research Trial (CONCOR-1), is a North American clinical trial designed to evaluate the efficacy and safety of COVID-19 convalescent plasma as a therapy for patients with COVID-19 respiratory illness. It involves collecting plasma containing neutralizing antibodies from individuals who…

Episode 10 – Interview with Dr. Sholzberg on COVID coagulopathy

Welcome back Rounds Table Listeners! This week we interviewed Dr. Michelle Sholzberg to discuss coagulopathy associated with COVID-19. Dr. Sholzberg is a clinical hematologist with a focus on bleeding and is the Medical Director of the Coagulation Laboratory at St. Michael’s Hospital in Toronto, Ontario, Canada. She is also the Co-Director of the Hematology-Oncology Clinical…

Episode 9 – COVID-19: Interview with Dr. Robbie Goldstein

Welcome back Rounds Table listeners! This week we interview Dr. Robbie Goldstein to find out how Mass General Hospital (MGH) in Boston has prepared, and adapted, to a massive influx of patients with COVID-19. Dr. Goldstein is an Instructor in Medicine at Harvard Medical School and an Infectious Disease physician at MGH. He is also…

Episode 8 – Rapid Fire: COVID-19 Part 2

Welcome back Rounds Table Listeners! This episode we discuss two recently published papers related to COVID-19. 1.       What is the incidence and significance of cardiac injury in patients with COVID-19 https://jamanetwork.com/journals/jamacardiology/fullarticle/2763524 2.      The clinical course and risk factors for mortality in a multi-centre cohort of inpatients with COVID-19 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30566-3/fulltext And for the good stuff: 1.       Calgary distillers and…

Episode 7 – Rapid Fire COVID-19

Welcome back Rounds Table Listeners! This episode, we’re focusing on 2 papers recently released related to COVID-19. 1.       Our first paper provides an overview of the clinical characteristics of a sample of patients admitted to hospital with COVID-19. https://www.nejm.org/doi/full/10.1056/NEJMoa2002032 2.       The second paper provides timely data to identify factors associated with ARDS among adults diagnosed with COVID-19.…

Episode 6 – Rapid Fire Cardiovascular

Welcome back for another episode of The Rounds Table! This episode Mike and John review 4 papers related to the latest and greatest in cardiovascular medicine. Check it out here: What is the efficacy and safety for using colchicine in myocardial infarction? (00:00 – 04:15) https://www.nejm.org/doi/full/10.1056/NEJMoa1912388 Do lower LDL targets improve outcomes for TIA or stroke? (04:15…

Rapid Fire: Respirology (And welcome back Drs. Kieran Quinn and Emily Hughes!)

Welcome back Rounds Table Listeners! For episode 5 we have two very special guests co-hosting. Welcome back to Drs. Kieran Quinn and Emily Hughes. This episode they discuss 4 articles on all things Respirology. Classic rapid fire format, let’s dive right in. Can the β-blocker, metoprolol, be used to prevent COPD exacerbations? (00:00 to 06:48)…

Rapid Fire: Infectious Disease

Happy New Year Rounds Table Listeners! We’re kicking off 2020 with an episode dedicated to all things Infectious Disease.  Classic Rapid Fire format…4 papers…here we go! Can patients be with gram negative bacteremia be treated safely with shorter courses of antibiotics? (https://academic.oup.com/cid/article/69/7/1091/5237874) (00:20 – 05:22) What is the impact of RSV infections on older adults?…

Rapid fire: High Value Care

Welcome back Rounds Table Listeners!   For episode 3, we have two very special guests co-hosting. Welcome back to Drs. Amol Verma and Kieran Quinn. This episode, they discuss 4 articles that peaked their interest related to high value care.   Classic Rapid Fire format…4 papers…here we go! Can care guided by patient priorities by associated with…

Surprise! We’re back…and talking all things cardiovascular…

  Rounds Table Listeners, we’ve got some good news for you… the Rounds Table is back! John and I have decided to pick up where Kieran and his excellent team left off; to continue to bring you regular podcasts on the latest and greatest internal medicine research. This reboot wouldn’t be possible without the continued…